Sign in

CIK 0000715446

  • Non-accelerated filer
  • Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
Operating
EIN
112622630
Phone
+1 408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Exercise or conversion Director acquired 60,000 shares (option exercise)
  3. 4 Exercise or conversion Chief Executive Officer acquired 500,000 shares (option exercise)
  4. 4 Open-market buy Chief Financial Officer bought 280,000 shares at $0.18 ($50,008)
  5. 4 Open-market buy Chief Executive Officer bought 1,400,000 shares at $0.18 ($250,040)
  6. 4 Open-market buy Director bought 280,000 shares at $0.18 ($50,008)
  7. 4 Open-market buy Director bought 1,400,000 shares at $0.18 ($250,040)
  8. 5 Insider Annual Insider Trading Report
  9. 5 Insider Annual Insider Trading Report
  10. 3 Insider Initial Statement of Ownership
  11. 5 Insider Annual Insider Trading Report
  12. 5 Insider Annual Insider Trading Report
  13. 4 Derivatives Options or other derivatives
  14. 4 Exercise or conversion VP - Finance & CFO acquired 100,000 shares (option exercise)
  15. 4 Exercise or conversion Chief Executive Officer acquired 100,000 shares (option exercise)
  16. 4 Open-market sale Vice President-Finance & CFO sold 76,000 shares at an average $0.38 ($29,095)
  17. 5 Insider Annual Insider Trading Report
  18. 4 Derivatives Options or other derivatives
  19. 5 Insider Annual Insider Trading Report
  20. 4 Derivatives Options or other derivatives

Page 21 of 24 · 471 filings